Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells

查看全文 作　　者：Erjala K;Sundvall M;Junttila TT; 出　　处：《Clin Cancer Res》索引2006年第12卷第13期,共0页